How can TARGIT-A have positive effects on reimbursement & guidelines?

This recorded clinical webinar starts with a brief overview about the global guideline situation for accelerated partial breast irradiation (APBI) giving insights into different guidelines like ASTRO, ASBrS or ESTRO. Following, Andrea McKee is discussing and comparing the TARGIT-A study with the NSABP B39 trial in-depth. Finally, she is focusing on the reimbursement situation for breast cancer in the United States by presenting the RO-APM reimbursement pilot affecting IORT treatments.